S4930 A Macroscopic Mystery: An Atypical Presentation of Microscopic Colitis

Introduction: Collagenous colitis (CC), a subtype of microscopic colitis, typically presents with chronic, non-bloody, watery diarrhea with a predilection towards an older, woman, population. While appearing endoscopically unremarkable, histologic findings are notable for a thickened subepithelial collagen band. We present a rare case of CC with endoscopic mucosal inflammation. Case Description/Methods: A 78-year-old woman presented with non-bloody diarrhea, urgency, incontinence, abdominal pain, and weight loss. Workup for additional etiologies of diarrhea (thyroid-stimulating hormone, celiac panel, fecal elastase, stool infectious studies) were unremarkable. An index colonoscopy revealed diffuse pancolonic inflammation. Pathology revealed focal surface erosion/denudation as well as thickening of a subepithelial collagen band felt to be consistent with CC. Budesonide and cholestyramine offered limited relief. In the setting of persistent symptoms and fecal calprotectin elevation to 2410 mcg/gm, vedolizumab was initiated. Despite dose escalation to every 4 weeks, vedolizumab yielded only a transient improvement in symptoms. A follow-up colonoscopy again showed diffuse endoscopic colonic congestion with a thickened collagen band on histology. Despite use of vedolizumab, colestipol 4 gm, budesonide 9 mg, and anti-diarrheals, the patient remained symptomatic with multiple bowel movements per day. The patient was subsequently changed to infliximab. She experienced a rapid, sustained, symptom resolution with normalized bowel frequency and resolution of urgency and incontinence. A follow up calprotectin improved to 67 mcg/gm. Discussion: This case illustrates an unusual presentation of CC with endoscopic inflammation, which deviates from the classic profile of this disease. The patient’s index colonoscopy did not clearly document pseudomembranes in the findings; however review of the endoscopic images suggests their presence. Ultimately, the patient was diagnosed with an atypical presentation of inflammatory bowel disease. This case underscores the importance of recognizing atypical features of collagenous colitis and maintaining a high index of suspicion for overlapping or evolving diagnoses, particularly in those who fail conventional therapy. This case also elevates the discussion of microscopic colitis as part of a spectrum of chronic inflammatory bowel diseases.

Authors

Publication Details

Journal
The American Journal of Gastroenterology
Published
2025-10-01
DOI
https://doi.org/10.14309/01.ajg.0001147180.65932.e4
Primary Topic
Microscopic Colitis
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

S4930 A Macroscopic Mystery: An Atypical Presentation of Microscopic Colitis

Scott Manski, Richard Pearce
The American Journal of Gastroenterology
Microscopic Colitis
article

S4930 A Macroscopic Mystery: An Atypical Presentation of Microscopic Colitis

Scott Manski, Richard Pearce
article en

Abstract

Introduction: Collagenous colitis (CC), a subtype of microscopic colitis, typically presents with chronic, non-bloody, watery diarrhea with a predilection towards an older, woman, population. While appearing endoscopically unremarkable, histologic findings are notable for a thickened subepithelial collagen band. We present a rare case of CC with endoscopic mucosal inflammation. Case Description/Methods: A 78-year-old woman presented with non-bloody diarrhea, urgency, incontinence, abdominal pain, and weight loss. Workup for additional etiologies of diarrhea (thyroid-stimulating hormone, celiac panel, fecal elastase, stool infectious studies) were unremarkable. An index colonoscopy revealed diffuse pancolonic inflammation. Pathology revealed focal surface erosion/denudation as well as thickening of a subepithelial collagen band felt to be consistent with CC. Budesonide and cholestyramine offered limited relief. In the setting of persistent symptoms and fecal calprotectin elevation to 2410 mcg/gm, vedolizumab was initiated. Despite dose escalation to every 4 weeks, vedolizumab yielded only a transient improvement in symptoms. A follow-up colonoscopy again showed diffuse endoscopic colonic congestion with a thickened collagen band on histology. Despite use of vedolizumab, colestipol 4 gm, budesonide 9 mg, and anti-diarrheals, the patient remained symptomatic with multiple bowel movements per day. The patient was subsequently changed to infliximab. She experienced a rapid, sustained, symptom resolution with normalized bowel frequency and resolution of urgency and incontinence. A follow up calprotectin improved to 67 mcg/gm. Discussion: This case illustrates an unusual presentation of CC with endoscopic inflammation, which deviates from the classic profile of this disease. The patient’s index colonoscopy did not clearly document pseudomembranes in the findings; however review of the endoscopic images suggests their presence. Ultimately, the patient was diagnosed with an atypical presentation of inflammatory bowel disease. This case underscores the importance of recognizing atypical features of collagenous colitis and maintaining a high index of suspicion for overlapping or evolving diagnoses, particularly in those who fail conventional therapy. This case also elevates the discussion of microscopic colitis as part of a spectrum of chronic inflammatory bowel diseases.

The American Journal of GastroenterologyVol. 120(10S2)
Openalex Percentile: Top 49%
Microscopic Colitis
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.